Granted, revenue has still been higher over the past few years than it was before COVID-19, but the stock price is also down ...

Twelve of the 15 analysts surveyed by S&P Global (NYSE: SPGI) in April rated the pharmaceutical stock as a "buy" or "strong ...

Four biotech stocks in the IBD 50 are in bases as first-quarter earnings rolls in. Travere Therepeutics is below a buy point ...

West Pharmaceutical Services, Inc. WST is well-positioned for growth, backed by strong demand for HVPs, expanding GLP-1 drug ...

The company's pipeline features almost 40 programs in late-stage clinical testing. These clinical trials are testing new drug candidates and seeking additional approvals for drugs such as Tremfya.

Vertex Pharmaceuticals' business will suffer if other drugmakers launch competing cystic fibrosis drugs. Despite this threat, ...

The Indian Pharmaceutical Market (IPM) grew 10.1% year-on-year in March 2026, according to the report. Pricing contributed ...

In this article, we will be taking a look at the 7 Oversold Pharma Stocks to Buy Now. In 2024, the pharmaceutical sector in the United States was valued at $634.32 billion, and by 2030, it is expected ...

Organon (OGN) stock jumped 41% after Sun Pharmaceutical submitted a $12B all-cash acquisition offer, backed by JPMorgan and ...

In this article, we will look at the 8 Most Undervalued Biotech Stocks to Buy Right Now. On April 13, Tom Lee, Fundstrat’s ...

PDS Biotech’s stock has jumped nearly 25% after its tumour-targeting fused antibody drug conjugate (ADC) elicited a 78% ...